C12Y 204/01125
Sucrose--1,6-alpha-glucan 3-alpha-glucosyltransferase
Official title: Sucrose--1,6-alpha-glucan 3(6)-alpha-glucosyltransferase (2.4.1.125)
C12Y204/01125 (Sucrose--1,6-alpha-glucan 3-alpha-glucosyltransferase) appears on 0 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 3
- Assignees
- 2
- Inventors
- 7
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Methods and compositions for treatment of forbes-cori disease1 Feb 2018US 2018/0028676 A1Valerion Therapeutics, LLC
- Enzymatic synthesis of soluble glucan fiber20 Jul 2017US 2017/0204442 A1E. I. Du Pont de Nemours and Company
- Methods and compositions for treatment of forbes-cori disease31 Mar 2016US 2016/0089451 A1Valerion Therapeutics, LLC
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.